- Home
- ZNTL vs CODA Comparison
ZNTL vs CODA Comparison
Compare ZNTL & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZNTL | CODA |
|---|---|---|
| Founded | 2014 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.3M | 98.9M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZNTL | CODA |
|---|---|---|
| Price | $1.43 | $8.98 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $5.87 | N/A |
| AVG Volume (30 Days) | ★ 495.7K | 44.1K |
| Earning Date | 11-10-2025 | 01-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.09 |
| EPS | N/A | ★ 0.30 |
| Revenue | ★ $26,865,000.00 | $24,347,217.00 |
| Revenue This Year | N/A | $30.82 |
| Revenue Next Year | N/A | $20.84 |
| P/E Ratio | ★ N/A | $30.17 |
| Revenue Growth | N/A | ★ 29.34 |
| 52 Week Low | $1.01 | $5.76 |
| 52 Week High | $3.72 | $10.54 |
Technical Indicators
Market Signals| Indicator | ZNTL | CODA |
|---|---|---|
| Relative Strength Index (RSI) | 52.35 | 52.90 |
| Support Level | $1.34 | $8.34 |
| Resistance Level | $1.45 | $9.14 |
| Average True Range (ATR) | 0.06 | 0.38 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 70.59 | 76.64 |
Price Performance
Historical ComparisonAbout ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.